Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone DJ Toufexis, C Davis, A Hammond, M Davis Journal of Neuroscience 24 (45), 10280-10287, 2004 | 102 | 2004 |
Discovery of a Novel Chemical Class of mGlu5 Allosteric Ligands with Distinct Modes of Pharmacology AS Hammond, AL Rodriguez, SD Townsend, CM Niswender, KJ Gregory, ... ACS chemical neuroscience 1 (10), 702-716, 2010 | 81 | 2010 |
Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone D Antoine, AS Huhn, EC Strain, G Turner, J Jardot, AS Hammond, ... The American Journal on Addictions 30 (1), 83-87, 2021 | 72 | 2021 |
Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male D Toufexis, C Davis, A Hammond, M Davis Journal of Neuroscience 25 (39), 9010-9016, 2005 | 59 | 2005 |
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement KJ Gregory, EJ Herman, AJ Ramsey, AS Hammond, NE Byun, SR Stauffer, ... Journal of Pharmacology and Experimental Therapeutics 347 (2), 438-457, 2013 | 52 | 2013 |
Synthesis, SAR and Unanticipated Pharmacological Profiles of Analogues of the mGluR5 Ago‐potentiator ADX‐47273 DW Engers, AL Rodriguez, R Williams, AS Hammond, D Venable, ... ChemMedChem: Chemistry Enabling Drug Discovery 4 (4), 505-511, 2009 | 43 | 2009 |
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health AS Hammond, MM Sweeney, TU Chikosi, ML Stitzer Journal of substance abuse treatment 126, 108425, 2021 | 34 | 2021 |
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper AS Huhn, PH Finan, CE Gamaldo, AS Hammond, A Umbricht, ... Science translational medicine 14 (650), eabn8238, 2022 | 29 | 2022 |
Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the … M Stitzer, T Matheson, C Cunningham, JL Sorensen, DJ Feaster, ... Addiction Science & Clinical Practice 12, 1-6, 2017 | 25 | 2017 |
The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone AS Huhn, RK Brooner, MM Sweeney, D Antoine, AS Hammond, H Ayaz, ... Addictive behaviors 113, 106673, 2021 | 15 | 2021 |
Enhancing patient navigation with contingent incentives to improve healthcare behaviors and viral load suppression of persons with HIV and substance use ML Stitzer, AS Hammond, T Matheson, JL Sorensen, DJ Feaster, R Duan, ... AIDS patient care and STDs 32 (7), 288-296, 2018 | 15 | 2018 |
Drug legalization and decriminalization beliefs among substance-using and nonusing individuals AS Hammond, KE Dunn, EC Strain Journal of addiction medicine 14 (1), 56-62, 2020 | 9 | 2020 |
TBPB is a highly selective M1 allosteric mscarinic receptor agonist in vitro and produces robust antipsychotic-like effects in vivo CK Jones, AE Brady, M Bubser, AY Deutch, LC Williams, AS Hammond, ... Neuropsychopharmacology 31, S116-S117, 2006 | 9 | 2006 |
A randomized and controlled acceptability trial of an internet-based therapy among inpatients with co-occurring substance use and other psychiatric disorders AS Hammond, DG Antoine, ML Stitzer, EC Strain Journal of Dual Diagnosis 16 (4), 447-454, 2020 | 7 | 2020 |
Perceived attitudes about substance use in anonymous social media posts near college campuses: Observational study AS Hammond, MJ Paul, J Hobelmann, AR Koratana, M Dredze, ... JMIR Mental Health 5 (3), e9903, 2018 | 5 | 2018 |
Drug-free community support in inpatients with co-occurring psychiatric disorders and substance use problems A Hammond, M Batkis, P Rostov, H Yan, M Kidorf Journal of dual diagnosis 18 (4), 177-184, 2022 | 2 | 2022 |
Patient attitudes toward technology-assisted treatment during hospital-based dual-diagnosis treatment AS Hammond, EC Strain, J Hsu, DG Antoine Drug and Alcohol Dependence 100 (156), e88, 2015 | 1 | 2015 |
Novel allosteric modulators of metabotropic glutamate receptors subtypes 2 and 5 for the treatment of schizophrenia CK Jones, F Xiang, A Jones, NE Byun, EA Hackler, AL Rodriguez, ... Neuropharmacology 55, 603-603, 2008 | 1 | 2008 |
The Impact of Child Protective Services Involvement on Pregnant and Postpartum Women in Substance Use Disorder Treatment D Colson-Fearon, DG Antoine, JM Peirce, M Kidorf, AS Hammond Substance Use & Misuse 58 (9), 1110-1114, 2023 | | 2023 |
Psychosocial Treatment Methods JM Peirce, DG Antoine, AS Hammond, MS Kidorf | | 2023 |